Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(17 sites)
United States
The Regents of the University of California||UC Davis Health, Rancho Cordova, California UC Davis Health, Sacramento, California UC Davis Ambulatory Care Clinic, Sacramento, California UC Davis Hemophilia Treatment Center, Sacramento, California UC Davis Medical Center, Sacramento, California UCSF Outpatient Hematology Clinic, San Francisco, California USF Health Morsani Center For Advanced Healthcare, Tampa, Florida The University of South Florida Board of Trustees, Tampa, Florida Mississippi Center For Advanced Medicine, Madison, Mississippi Cornell University||Joan & Sanford I. Weill Medical College, New York, New York Weill Cornell Medical College-New York Presbyterian Hospital, New York, New York The Childrens Hospital of Philadelphia Division of Hematology, Philadelphia, Pennsylvania Washington Institute for Coagulation, Seattle, Washington Australia
Royal Prince Alfred Hospital, Camperdown, New South Wales Sydney Local Health District (RPAH Zone), Camperdown, New South Wales Taiwan
National Taiwan University Hospital, Taipei Turkey (Türkiye)
Ege Universitesi Hastanesi, Izmir, İ̇zmir